PMDA — authorised 28 March 2022
- Marketing authorisation holder: Takeda Pharmaceutical Company Limited
- Status: approved
🇯🇵 Takhzyro in Japan
PMDA authorised Takhzyro on 28 March 2022
Marketing authorisation
Takhzyro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Takhzyro approved in Japan?
Yes. PMDA authorised it on 28 March 2022.
Who is the marketing authorisation holder for Takhzyro in Japan?
Takeda Pharmaceutical Company Limited holds the Japanese marketing authorisation.